Messenger RNA vaccines reduce the risk of infection by 91%

According to a new study, COVID-19 messenger RNA vaccines reduce the risk of infection by 91% in fully vaccinated people. Some cases who develop the disease have far less severe symptoms.

A variety of vaccines are used on a laboratory basis in the fight against Kovid-19 around the world. here is Messenger RNA Vaccines, Subunit Protein Vaccines and Viral Vector Vaccines. They all share the same goal of protecting vaccinated people against COVID-19, but they don’t work in the same way.

COVID-19 Vaccine – Credits: Mufid Majnoon / Unsplash

The messenger RNA vaccine contains a portion of the RNA of the coronavirus, SARS-CoV-2. one time injection, The messenger RNA protein of the vaccine is S. gets converted into (spike) in cells. This triggers an immune response to defend the body against this S protein. If a vaccinated person is then infected with SARS-CoV-2, their immune system is able to recognize the S protein and thus destroy it. In addition, researchers have recently discovered a therapy that cheats and traps the S protein of the coronavirus.

Messenger RNA vaccines reduce the risk of infection by 81% after a single dose

Researchers at the University of Utah Health have studied the effectiveness of messenger RNA vaccines in protecting against the coronavirus. For your information, let us tell you that these vaccines are specially Modern and Pfizer / BioNTech Which has got very good results so far. In Israel, people vaccinated with Pfizer/BioNTech developed 20 times more antibodies than survivors.

People “fully vaccinated” with messenger RNA vaccine, according to new study 91% less chance of contracting Covid-19. They are considered fully vaccinated two weeks after the second dose. For partial vaccination, ie two weeks after the first dose, messenger RNA vaccines are reduced 81% risk of infection. Some people who still have the infection have less severe symptoms of COVID-19. The latter also lasts less long, according to the study.

READ  An app to find your sense of smell

Study co-author Sarang Yoon said that ” A striking feature of this study is that it measured the secondary benefits of the vaccine. We have administered these vaccines to some of the highest risk groups in this country. “. about this Medical personnel who regularly contract SARS-CoV-2 . come in contact with. « The vaccine protected him from the disease. People who unfortunately contracted COVID-19 despite being vaccinated were always better off than those who didn’t Sarang Yun said. In the end, it confirms how important it is to receive the recommended two doses of the COVID-19 vaccine.

Source: Science Daily

You May Also Like

About the Author: Abbott Hopkins

Analyst. Amateur problem solver. Wannabe internet expert. Coffee geek. Tv guru. Award-winning communicator. Food nerd.

Leave a Reply

Your email address will not be published. Required fields are marked *